| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |